Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Quantum Biopharma (QNTM) Equity Ratio (2021 - 2025)

Quantum Biopharma's Equity Ratio history spans 4 years, with the latest figure at 0.62 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 7.49% to 0.62 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.62, a 7.49% decrease, with the full-year FY2025 number at 0.62, down 7.49% from a year prior.
  • Equity Ratio hit 0.62 in Q4 2025 for Quantum Biopharma, up from 0.61 in the prior quarter.
  • Over the last five years, Equity Ratio for QNTM hit a ceiling of 0.86 in Q4 2021 and a floor of 0.25 in Q2 2025.
  • Historically, Equity Ratio has averaged 0.64 across 4 years, with a median of 0.67 in 2024.
  • The widest YoY moves for Equity Ratio: up 7.49% in 2025, down 65.77% in 2025.
  • Tracing QNTM's Equity Ratio over 4 years: stood at 0.86 in 2021, then dropped by 7.51% to 0.8 in 2022, then fell by 15.66% to 0.67 in 2024, then decreased by 7.49% to 0.62 in 2025.
  • Business Quant data shows Equity Ratio for QNTM at 0.62 in Q4 2025, 0.61 in Q3 2025, and 0.25 in Q2 2025.